Skip to content
Screener

Bioventus BVS Intangibles (Net)

Intangibles (Net) at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$65.97M-16.4%
Anika Therapeutics logo
Anika TherapeuticsANIK
$1.65M-0.7%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$4.46B-8.8%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$252K-96.6%
Medtronic logo
MedtronicMDT
$10.15B-13.0%
Globus Medical logo
Globus MedicalGMED
$692.62M-13.0%

Other financials

Income statement

See full
Revenue$153.2M+3.8%
Gross profit$105.7M+3.5%
Operating income$19.1M+4.1%
Net income$33.4M+348%
EPS (diluted)$0.47+327%

Balance sheet

See full
Cash & equivalents$29.5M-10.5%
Total debt$263.7M-26.9%
Total equity$228.3M+41.6%
Total assets$673.3M-4.7%

Cash flow

See full
Operating cash flow$19.9M-23.4%
CapEx$960.0K+40.6%
Free cash flow$18.9M-25.1%

Valuation

See full
Market cap$1.19B+153%
Enterprise value$1.42B+78.0%
P/E21.8×
P/S+1.2×

Profitability

See full
Gross margin68.7%+1.1pp
Operating margin10%
Net margin9.4%+9.2pp
FCF margin16.2%+10.2pp

Returns & leverage

See full
Return on equity28%+27.5pp
Debt / equity1.2×-1.1×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The source filing: Bioventus’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:43 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001665988-26-000042
Line itemJune 27, 2026December 31, 2025
Total current assets257,527272,842
Property and equipment, net20,52721,899
Goodwill7,4627,462
Intangible assets, net351,046368,419
Operating lease assets4,2255,122
Deferred tax assets29,0525,522
Investment and other assets3,5072,293
Total assets$673,346$683,559

Item 1. Financial Statements (Unaudited)

FAQ

What is Bioventus's intangibles (net)?
Bioventus (BVS) reported intangibles (net) of $351.05M in Q2 2026.
How has Bioventus's intangibles (net) changed year-over-year?
Bioventus's intangibles (net) decreased by 9.3% year-over-year, from $386.95M to $351.05M.
What is the long-term trend for Bioventus's intangibles (net)?
Over 5 years (2020 to 2025), Bioventus's intangibles (net) has grown at a 14.0% compound annual growth rate (CAGR), from $191.65M to $368.42M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about Bioventus's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude